An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
This study investigates the effects of an investigational medication compared to a placebo in adults with high-risk asthma. The purpose is to evaluate the safety and effectiveness of this add-on therapy in participants who are not eligible for biologic treatments. Participants will be involved in the study for about 64 …
This study investigates chronic rhinosinusitis with nasal polyps (CRSwNP). The purpose of the study is to evaluate how effective and safe an investigational medication is when used with nasal sprays in adults with CRSwNP. Participants will be in the study for up to 76 weeks, which includes time for screening, …
This study investigates the safety and immune response (immunogenicity) of an investigational vaccine, referred to as vYF, in young children. The purpose is to compare vYF with two licensed vaccines, Stamaril and YF-VAX, when given alone or alongside the Measles Mumps Rubella (MMR) vaccine in infants aged 11-15 months. Immunogenicity …
This study investigates the effects and safety of an investigational medication in children aged 2 to less than 6 years who have uncontrolled asthma or severe asthmatic wheeze. The purpose is to understand how well the medication works and how safe it is for long-term use in this age group. …
This study investigates the long-term safety and efficacy of an investigational medication in adults with asthma. It is an extension of previous studies and will last up to 100 weeks, with participants receiving treatment for up to 96 weeks. The purpose of this study is to continue monitoring the effects …
This study investigates the treatment of moderate-to-severe atopic dermatitis in participants aged 12 years and older. The purpose is to evaluate the efficacy and safety of an investigational medication given as a subcutaneous injection, compared to a placebo. Participants will continue using their topical corticosteroids (TCS) during the study. The …
The purpose of this study is to investigate the long-term effects of an investigational medication on preventing lung function decline in adults with uncontrolled moderate to severe asthma. The study will last for a total of 3 years, following a screening and run-in period of about 4 weeks. Participants will …
This study investigates the effects of an investigational medication compared to a daily oral dose of another treatment in adults with relapsing forms of multiple sclerosis. The study will last at least 12 months for the last participant and could be up to 40 months or longer for the first …
The purpose of this study is to investigate the effects of investigational medications on primary focal segmental glomerulosclerosis (FSGS) and primary minimal change disease (MCD) in participants aged 16 to 75 years. The study will last up to 76 weeks, and participants will be involved for this entire duration. FSGS …
